Concord Medical Co., Ltd. (TPEX:6518)
25.65
+0.80 (3.22%)
Jul 1, 2025, 10:22 AM CST
Concord Medical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 49.57 | 42.74 | 50.66 | 34.4 | 19.77 | Upgrade
|
Depreciation & Amortization | 86.22 | 79.43 | 75.99 | 96.25 | 102.88 | Upgrade
|
Other Amortization | - | - | 0.43 | 0.34 | 0.32 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.15 | -0.41 | -1.69 | -9.16 | -1.85 | Upgrade
|
Provision & Write-off of Bad Debts | 1.02 | 0.17 | -0.69 | -1.84 | -0.13 | Upgrade
|
Other Operating Activities | 3.35 | -5.33 | 3.91 | 3.63 | -2.84 | Upgrade
|
Change in Accounts Receivable | 4.45 | 9.48 | -2.72 | 6.64 | -19.21 | Upgrade
|
Change in Inventory | -1.43 | 2.02 | 3.18 | -6.53 | 0.79 | Upgrade
|
Change in Accounts Payable | 4.32 | -15.14 | 17.83 | 0.67 | 15.41 | Upgrade
|
Change in Unearned Revenue | - | - | - | - | -0.45 | Upgrade
|
Change in Other Net Operating Assets | 1.48 | 0.26 | 7.66 | 13.02 | -30.66 | Upgrade
|
Operating Cash Flow | 148.83 | 113.23 | 154.56 | 137.42 | 84.07 | Upgrade
|
Operating Cash Flow Growth | 31.45% | -26.74% | 12.47% | 63.47% | -35.86% | Upgrade
|
Capital Expenditures | -74.72 | -88.18 | -37.46 | -21.8 | -93.64 | Upgrade
|
Sale of Property, Plant & Equipment | 3.16 | 4.47 | 19.84 | 30.88 | 35.41 | Upgrade
|
Sale (Purchase) of Intangibles | -1.65 | -1.51 | -0.61 | 24.19 | -0.39 | Upgrade
|
Investment in Securities | -22.5 | -109 | -97.23 | - | 2.59 | Upgrade
|
Other Investing Activities | 3.38 | 6.14 | 5.15 | -0.1 | 1.18 | Upgrade
|
Investing Cash Flow | -92.33 | -188.08 | -110.31 | 33.17 | -54.86 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 67.86 | Upgrade
|
Long-Term Debt Issued | - | 35 | - | - | 0.02 | Upgrade
|
Total Debt Issued | - | 35 | - | - | 67.88 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -76.36 | Upgrade
|
Long-Term Debt Repaid | -24.69 | -22.11 | -19.58 | -120.69 | -27.98 | Upgrade
|
Total Debt Repaid | -24.69 | -22.11 | -19.58 | -120.69 | -104.33 | Upgrade
|
Net Debt Issued (Repaid) | -24.69 | 12.89 | -19.58 | -120.69 | -36.46 | Upgrade
|
Issuance of Common Stock | - | - | - | 100 | - | Upgrade
|
Common Dividends Paid | -33.33 | -33.33 | -16.67 | -10 | -10 | Upgrade
|
Other Financing Activities | - | -40.35 | 40.11 | -0.53 | -0.06 | Upgrade
|
Financing Cash Flow | -58.02 | -60.8 | 3.87 | -31.22 | -46.52 | Upgrade
|
Net Cash Flow | -1.51 | -135.65 | 48.11 | 139.38 | -17.31 | Upgrade
|
Free Cash Flow | 74.12 | 25.05 | 117.1 | 115.63 | -9.58 | Upgrade
|
Free Cash Flow Growth | 195.91% | -78.61% | 1.27% | - | - | Upgrade
|
Free Cash Flow Margin | 8.33% | 3.01% | 13.17% | 15.65% | -1.18% | Upgrade
|
Free Cash Flow Per Share | 2.21 | 0.75 | 3.51 | 4.61 | -0.38 | Upgrade
|
Cash Interest Paid | 3.55 | 3.52 | 3.51 | 4.79 | 6.2 | Upgrade
|
Cash Income Tax Paid | 10.1 | 16.6 | 9.5 | 4.59 | 8.53 | Upgrade
|
Levered Free Cash Flow | 54.59 | 16.19 | 108.82 | 121.36 | -11.7 | Upgrade
|
Unlevered Free Cash Flow | 56.81 | 18.39 | 111.01 | 124.35 | -7.76 | Upgrade
|
Change in Net Working Capital | -8.96 | 5.57 | -32.18 | -1.95 | 34.48 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.